Ten-day decitabine with venetoclax (DEC10-VEN) in AML and high-risk (HR) MDS.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Abhishek Maiti, Courtney Denton Dinardo, Naveen Pemmaraju, Tapan M. Kadia, Caitlin R Rausch, Kiran Naqvi, Naval Guastad Daver, Gautam Borthakur, Maro Ohanian, Ghayas C. Issa, Yesid Alvarado, Nicholas James Short, Michael Andreeff, Elias Jabbour, Sherry A. Pierce, Farhad Ravandi, Guillermo Garcia-Manero, John Sutton Welch, Hagop M. Kantarjian, Marina Konopleva
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3028729965